Joyce Weaver
Impact in
- Pharmacology top 10%
- Pharmacology and Obesity Treatment
- Drug-Induced Adverse Reactions
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Drug-Induced Adverse Reactions 2
- Pharmaceutical industry and healthcare 2
- Pharmacology and Obesity Treatment 1
- Pharmacogenetics and Drug Metabolism 1
- Inflammatory mediators and NSAID effects 1
-
- Pharmacovigilance and Adverse Drug Reactions 2
- Co-authors
- Amy Egan (1 shared paper)Curtis J. Rosebraugh (1 shared paper)Julie K. Golden (1 shared paper)Eric G Colman (1 shared paper)Mark Avigan (2 shared papers)Lois La Grenade (2 shared papers)Mary E. Willy (1 shared paper)Claudia B. Karwoski (2 shared papers)
- Journals
- New England Journal of Medicine (1 paper)Libri (1 paper)Drug Safety (1 paper)The American Journal of Gastroenterology (1 paper)The AAPS Journal (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Joyce Weaver
5 papers receiving 259 citations
Peers
Comparison fields: 5 of 64
- Pharmacology 158
- Toxicology 31
- Endocrinology, Diabetes and Metabolism 52
- Endocrine and Autonomic Systems 20
- Physiology 65
Countries citing papers authored by Joyce Weaver
This map shows the geographic impact of Joyce Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Weaver more than expected).
Fields of papers citing papers by Joyce Weaver
This network shows the impact of papers produced by Joyce Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Weaver. The network helps show where Joyce Weaver may publish in the future.
Co-authors
The 13 scholars most cited alongside Joyce Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 153 | |
| 2 | 2005 | 65 | |
| 3 | 2008 | 37 | |
| 4 | 2009 | 17 | |
| 5 | 2001 | 6 | |
| 6 | 1999 | 0 |
About Joyce Weaver
Joyce Weaver is a scholar working on Pharmacology, Pharmacology, Toxicology, Library and Information Sciences and Endocrinology, Diabetes and Metabolism, having authored 6 papers that have together received 278 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Pharmaceutical industry and healthcare (2 papers), Pharmacology and Obesity Treatment (1 paper), Diabetes Treatment and Management (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Pharmacology (158 citations), Toxicology (31 citations), Endocrinology, Diabetes and Metabolism (52 citations), Endocrine and Autonomic Systems (20 citations) and Physiology (65 citations). Joyce Weaver has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Amy Egan, Curtis J. Rosebraugh, Julie K. Golden, Eric G Colman, Mark Avigan, Lois La Grenade, Mary E. Willy, Claudia B. Karwoski, Allen D. Brinker and Renan A. Bonnel. Their work appears in journals such as New England Journal of Medicine, Libri, Drug Safety, The American Journal of Gastroenterology and The AAPS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.